|
|
| (11) | Number of the document | C 1773816 |
| (68) | Number of the document | 1773816 |
| (21) | Application number for Supplementary Protection Certificate | PA 2015 028 |
| (22) | Date of filing the application | 2015-07-03 |
| (41) | Date of publication of the application | 2015-08-25 |
| Date of publication of SPC | 2017-06-26 | |
| (24) | Date of coming into effect of SPC | 2025-06-25 |
| (71) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/12/782/001 - EU/1/12/782/002, 2, 0012-07-23 |
| (94) | 2027-07-25 |
| (95) | Ivakaftoras arba jo farmaciniu požiūriu priimtina druska |
| Request filed | SPC extension granted until | Request refused | |
| 2025-07-23 | 2028-01-25 |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 1 | 347.00 EUR |
| 2026-06-25 |
| SPC term extension granted |